| 1 |
gastroenteropancreatic neuroendocrine tumors
(109 times)
|
Neoplasms
(26 times)
|
PRRT (14 times)
MEN1 (7 times)
SSTR (7 times)
|
2004 Somatostatin and other Peptide receptors as tools for tumor diagnosis and treatment.
|
| 2 |
gastroenteropancreatic NET
(8 times)
|
Endocrinology
(3 times)
|
NET (6 times)
NETs (2 times)
18F-FDOPA (1 time)
|
2010 Yttrium-90 DOTATOC therapy in GEP-NET and other SST2 expressing tumors: a selected review.
|
| 3 |
Gastorenteropancreatic neuroendocrine
(1 time)
|
Gastroenterology
(1 time)
|
---
|
2022 Clinicopathological Characteristics of Gastroenteropancreatic Neuroendocrine Tumors: 10 Years of Experience From a Single Center.
|
| 4 |
gastro-enteropancreatic tract
(1 time)
|
Endocrinology
(1 time)
|
MEN1 (1 time)
NET (1 time)
|
2011 Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study.
|
| 5 |
gastroenteropancreatic system
(1 time)
|
Internal Medicine
(1 time)
|
NET (1 time)
|
2012 [Surgery for neuroendocrine tumors of the gastroenteropancreatic system (GEP-NET)].
|
| 6 |
gastroenteropancreatic tumours
(1 time)
|
Nuclear Medicine
(1 time)
|
PI (1 time)
PRRT (1 time)
|
2010 Impact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapy.
|
| 7 |
gastrointestinal neuroendocrine neoplasms
(1 time)
|
General Surgery
(1 time)
|
NIFTP (1 time)
PC (1 time)
PGL (1 time)
|
2021 [Endocrine and neuroendocrine tumors].
|
| 8 |
gastrointestinal tract and pancreas
(1 time)
|
Endocrinology
(1 time)
|
---
|
2011 Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreas.
|
A Search Service for Abbreviation / Long Form